Press release
Update in Lawsuit that was filed for Investors in Obalon Therapeutics Inc (NASDAQ: OBLN) shares
A lawsuit is pending for certain investors in Obalon Therapeutics Inc (NASDAQ: OBLN) shares and Obalon Therapeutics Inc.
Investors who purchased shares of Obalon Therapeutics Inc (NASDAQ: OBLN) and currently hold any of those Obalon Therapeutics Inc (NASDAQ: OBLN shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On February 14, 2018, a lawsuit was filed against Obalon Therapeutics Inc (NASDAQ: OBLN) over alleged securities laws violations. The plaintiff alleged that the Defendants failed to disclose that Obalon Therapeutics Inc recognized revenue in violation of Generally Accepted Accounting principles (“GAAP”), that the Company lacked adequate internal controls over accounting and financial reporting, and that, as a result of the foregoing, Obalon Therapeutics Inc’s financial statements and Defendants’ statements about Obalon’s business, operations, and prospects, were materially false and misleading at all relevant times. Recently the court denied in part a motion by the defendants to dismiss the case and the case is moving forward.
Those who purchased shares of Obalon Therapeutics Inc (NASDAQ: OBLN), have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Update in Lawsuit that was filed for Investors in Obalon Therapeutics Inc (NASDAQ: OBLN) shares here
News-ID: 1842091 • Views: …
More Releases from Shareholders Foundation
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd.
Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…
More Releases for Obalon
Weight-Loss Devices Market Report Analysis, Research Studies | ReShape Lifescien …
DataM Intelligence has published a new research report on "Weight-Loss Devices Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF -…
Weight-Loss Devices Market Trends and Growth Opportunities in 2024 Obalon Therap …
The Weight-Loss Devices Market encompasses a diverse array of medical devices and technologies designed to aid individuals in achieving weight reduction and managing obesity-related health conditions. This market segment is witnessing steady growth globally, driven by factors such as the rising prevalence of obesity and associated health complications, increasing awareness about the importance of weight management, and advancements in medical technology.
Get a free sample copy of the report:-https://www.datamintelligence.com/download-sample/weight-loss-devices-market
Market Trends :
Technological…
New Comprehensive Report on Obesity Intervention Devices Market 2020-2027| Enter …
HealthCare Intelligence Markets unravels its new study titled Obesity Intervention Devices Market. Effective exploratory techniques such as qualitative and quantitative analysis have been used to discover accurate data. For an effective business outlook, it studies North America, Latin America, Asia-Pacific, Japan, and India by considering different aspects such as type, size, as well as applications. SWOT and Porter’s five analysis have been used to analyse cost, prices, revenue, and end-users.…
Intragastric Balloon Market In depth research analysis| Key Player: Allurion Tec …
The Intragastric Balloons Market size is expected to exceed USD 270 million by 2024; as per a new research report by Global Market Insights.
Strong obesity and associated disease prevalence will drive the industry, increasing healthcare expenditure and improved awareness regarding early diagnosis of obesity will fuel business growth. Growing acceptance of minimally invasive techniques should also fuel intragastric balloons market growth. Positive regulatory approval rates of these systems have evolved…
Intragastric Balloon Market| Key Player: Allurion Technologies, Silimed, Distric …
The Intragastric Balloons Market size is expected to exceed USD 270 million by 2024; as per a new research report by Global Market Insights.
Strong obesity and associated disease prevalence will drive the industry, increasing healthcare expenditure and improved awareness regarding early diagnosis of obesity will fuel business growth. Growing acceptance of minimally invasive techniques should also fuel intragastric balloons market growth. Positive regulatory approval rates of these systems have evolved…
Intragastric Balloon Market| Key Player: Allurion Technologies, Silimed, Distric …
The Intragastric Balloons Market size is expected to exceed USD 270 million by 2024; as per a new research report by Global Market Insights.
Strong obesity and associated disease prevalence will drive the industry, increasing healthcare expenditure and improved awareness regarding early diagnosis of obesity will fuel business growth. Growing acceptance of minimally invasive techniques should also fuel intragastric balloons market growth. Positive regulatory approval rates of these systems have evolved…
